Role of Interlekin-35 as a Biomarker in Patients With Newly Diagnosed Hashimoto’s Thyroiditis

Endocrine Regulations - Germany
doi 10.1515/enr-2016-0009
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Walter de Gruyter GmbH

Related search

Hashimoto’s Thyroiditis

2014English

Hashimoto’s Thyroiditis and Encephalopathy

World Journal of Neuroscience
2017English

Th17/Treg Cells Imbalance and GITRL Profile in Patients With Hashimoto’s Thyroiditis

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2014English

Plasma YKL-40 as a Biomarker for Bevacizumab Efficacy in Patients With Newly Diagnosed Glioblastoma in the Phase 3 Randomized AVAglio Trial

Oncotarget
Oncology
2017English

Hashimoto’s Thyroiditis and Autoimmune Gastritis

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2017English

Cognitive Function in Hashimoto’s Thyroiditis Under Levothyroxine Treatment

Hormones
MedicineEndocrinologyMetabolismDiabetes
2014English

Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients With Multiple Sclerosis

PLoS ONE
Multidisciplinary
2014English

Research Progress on IgG4-Related Hashimoto’s Thyroiditis

Infection International
2015English

Effect of L-Thyroxine Treatment on Peripheral Blood Dendritic Cell Subpopulations in Patients With Hashimoto’s Thyroiditis

Folia Histochemica et Cytobiologica
MedicineForensic MedicinePathologyHistology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy